NCT01494558View on ClinicalTrials.gov

Study of Etoposide, Cisplatin, and Radiotherapy Versus Paclitaxel, Carboplatin and Radiotherapy to Treat Non-Small Cell Lung Cancer

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

October 31, 2010

Study Completion Date

August 31, 2011

Conditions
Non-Small Cell Lung Cancer
Interventions
OTHER

Chemoradiotherapy Regimen between PC and PE

etoposide 50mg/m2 d1-5, 29-33 and cisplatin 50mg/m2 d1,8,29 and 36 29-33 during radiotherapy paclitaxel 45mg/m2 weekly and carbplatin AUC =2mg/mL/min weekly during radiotherapy

All Listed Sponsors
lead

Chinese Academy of Medical Sciences

OTHER

NCT01494558 - Study of Etoposide, Cisplatin, and Radiotherapy Versus Paclitaxel, Carboplatin and Radiotherapy to Treat Non-Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter